Moreover, in its recent paper position of 2018, the international public health regulatory body, takes a tough call on rabies vaccines, replacing its 2010 position paper. The position paper elaborates in the novel advancements in the field of Rabies Diagnostics, with a focus on programmatic viabilities, simplified vaccination programs, and cost-effectiveness of rabies diagnostics. WHO recommends pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) as the two new immunization strategies.
Apart from such programs, other key growth drivers include:
- Veterinaries are increasingly approving point-of-care rabies diagnostic solutions
- Increased willingness and focus of pet owners ensure the overall health and pay for animal health services—directly or through either various pet insurance programs
- Increased novel innovations in rabies diagnostic solutions
Obtain an enticing sample report accompanied by visually appealing graphs and charts. Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7770
Moreover, in its recent paper position of 2018, the international public health regulatory body, takes a tough call on rabies vaccines, replacing its 2010 position paper. The position paper elaborates in the novel advancements in the field of rabies diagnostics, with a focus on programmatic viabilities, simplified vaccination programs, and cost-effectiveness of rabies diagnostics. WHO recommends pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) as the two new immunization strategies.
Apart from such programs, other key growth drivers include:
- Veterinaries are increasingly approving point-of-care rabies diagnostic solutions
- Increased willingness and focus of pet owners ensure the overall health and pay for animal health services—directly or through either various pet insurance programs
- Increased novel innovations in rabies diagnostic solutions
Rabies Elimination Programs in Developing, Low-Resource Countries to Push Revenue in Global Rabies Diagnostics Market
Of the 59,000 reported rabies-related deaths, globally, most of them are reported from the low-income settings—with India reporting the highest number of such deaths. As per Association for the Prevention and Control of Rabies in India’s (APCRI) 2018 journal, India accounts for nearly 36 percent of worldwide rabies deaths, with the nation reporting nearly 20,000 deaths, annually.
The country is also said to have the maximum number of stray dogs, compared to any other country, further driving the demand for rabies diagnostics. Moreover, Kenya’s efforts to eliminate rabies by 2030, includes, mass dog vaccinations, provision of post-exposure prophylaxis (PEP), public awareness, improved surveillance, and quick response to rabies outbreak.
Uncover More Information by Clicking on the Provided Link Request a TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7770
Several Asian countries have adopted Intradermal regimes. Such instances has prompted companies and global health regulatory bodies to invest in the research and development of effective rabies diagnostic tools. However, high cost of PEP to governments is anticipated to disrupt the supply chain and challenge its availability, thereby translating into increased risks and higher out-of-pocket payments.
Rabies Diagnostics Market to Witness Novel Treatment Innovations by Key Players
The Center for Disease Control and Prevention (CDC) recently launched a new rabies test, for a more superior diagnoses of rabies. The newly launched LN34 pan-lyssavirus real-time polymerase chain reaction (PCR) assay (LN34) showcased a higher diagnostic capability compared to the current standard direct fluorescent antibody (DFA) test.
The LN34 is said to be much more robust and reliable versus the standard rabies diagnostics tests, and also replace DFA to become the most preferred test for rabies diagnosis. Moreover, the new LN34 does not require any specialized training or lab set-ups and can be used in a variety of settings.
Additionally, LN34 has said to take-off the economic burden and lessen the treatment regime. Development of such advancement rabies diagnostic tools could result in a shift the epidemiology of rabies—resulting in a more superior rabies identification and treatment protocol, thereby, reducing further rabies-related mortality rates.
Connect with Industry Experts and Get Expert Advice.Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-7770
Additionally, Nacimbio and Lomonosov MSU are planning to together conduct research programs to develop innovative immunobiological drugs for rabies. Other key players, making advancements in the rabies diagnostics market include, Merck KGaA, Bio-Rad Laboratories, Inc, Aviva Systems Biology Corporation, and Abbexa Ltd among others.
Segmentation of the Global Rabies Diagnostics Market
The report on Rabies Diagnostics Market, broadly classifies the market in the basis of end user:
- Hospitals.
- Diagnostic centers.
- Cancer Palliative care clinics.
- Pharmacies.
The report onRabies Diagnostics Marketalso offers an elaborate regional analysis, including market opportunities and competitive scenario in each region:
- North America Rabies Diagnostics Market(U.S., Canada)
- Latin America Rabies Diagnostics Market(Mexico, Brazil, Rest of Latin America)
- Western Europe Rabies Diagnostics Market(France, Germany, Italy, Spain, U.K.)
- Eastern Europe Rabies Diagnostics Market(Poland, Russia)
- Japan Rabies Diagnostics Market
- Asia Pacific excluding Japan Rabies Diagnostics Market(India, China, ASEAN, New Zealand, Australia)
- Middle East and Africa Rabies Diagnostics Market(N. Africa, S. Africa, GCC countries, Rest of MEA)
The Rabies Diagnostics Marketresearch offers exclusive insights on the aforementioned market. Apart from a thorough segmental analysis, the report also provides thorough assessment of the trends in the parent market, macro-economic metrics, market governing factors, and market attractiveness based on segments. Other aspects covered in the rabies diagnostics market, includes:
- Detailed analysis of the parent market
- Key market dynamics influencing the global rabies diagnostics market
- Elaborate segment analysis
- Rabies diagnostics market Size in terms of Volume and Value: Current, Historical and Projected Data
- Trends and Opportunities in rabies diagnostics market
- Competitive Landscape of global rabies diagnostics market, along with analysis of key companies along with their key market strategies
- Geographies and Potential and Niche Segments that exhibit promising growth
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.
Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.
Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
